Cadila Healthcare

A great rally

Posted by : LEO THE LION
Price when posted : BSE: Rs 495.55 ( 0.82 % ), NSE: Rs. 494.85 ( 0.77 % )

Cadila performed best an rallied from 330 to 510 in shorttime. the expected one.....and a much awaited one....

Towards Clinical trail for H 1 N 1

Posted by : ifonly
Price when posted : BSE: Rs 444.10 ( 1.29 % ), NSE: Rs. 444.65 ( 1.63 % )

That Cadila (CPL) is different and is unlisted....

BSE Announcements on Cadila Health

Posted by : MMB Messenger
Price when posted : [Cadila Health - BSE:Rs. 444.10 NSE:Rs. 238.15 when posted]

Cadila Healthcare Ltd has informed BSE that the 14th Annual General Meeting (AGM) of the Company was held on July 29, 2009....

NSE Announcements on Cadila Health

Posted by : MMB Messenger
Price when posted : [Cadila Health - BSE:Rs. 438.45 NSE:Rs. 238.15 when posted]

Cadila Healthcare Limited has submitted to the Exchange a copy of the Proceedings of the Annual General Meeting of the shareholders of the Company held on July 29, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...

Towards Clinical trail for H 1 N 1

Posted by : rvk41
Price when posted : BSE: Rs 445.50 ( 2.93 % ), NSE: Rs. 443.40 ( 3.53 % )

With an aim to launch vaccine for Influenza H1N1 A Virus (swine flu) in India, Cadila Pharmaceutical will seek the government`s nod in two days for initiating clinical trials in this regard.

Cadila Pharmaceutical Ltd (CPL) had set up a joint venture `CPL Biologicals Pvt Ltd` with the US-based vaccine maker Novavax for manufacturing and developing a host of vaccines, including for swine flu, in India.

"The joint venture is going to file the application with the Drug Controller General of India (DCGI) in the next two days for phase-I clinical trials for swine flu vaccine," CPL Chairman and Managing Director, I A Modi told PTI.

Modi expressed confidence that Cadila would be the first Indian pharma company to launch the swine flu vaccine in India by December. "If we get the permission of DCGI soon, then with the advanced technology available from our partner, (we) would be able to launch it in India by December this year," Modi said.

For information,with regards
rvk41...

NSE Announcements on Cadila Health

Posted by : MMB Messenger
Price when posted : [Cadila Health - BSE:Rs. 432.80 NSE:Rs. 238.15 when posted]

Cadila Healthcare Limited has informed the Exchange that the letter bearing reference no. AC/CR/CHL/2009/CH3950 dated July 23, 2009 issued by CRISIL Rating for the Rs.1250 million Short Term Debt Programme (including Commercial Paper Programme) of the Company enhanced from Rs.600 million....

H1N1 virus drug

Posted by : shonn
Price when posted : BSE: Rs 432.80 ( -1.64 % ), NSE: Rs. 428.30 ( -3.17 % )

As per news today in ToI, Cadilla has aquired drug manufacturing rights from its US based sister concern & approached Govt to allow it to sell this drug & also hoped to sell atleast 2lacs doses per month....

BSE Announcements on Cadila Health

Posted by : MMB Messenger
Price when posted : [Cadila Health - BSE:Rs. 440.00 NSE:Rs. 238.15 when posted]

Cadila Healthcare Ltd has informed BSE regarding the letter dated July 23, 2009 issued by CRISIL Rating for the Rs 1250 million Short Term Debt Programme (including Commercial Paper Programme) of the Company enhanced from Rs 600 million....

Accmulate Cadila

Posted by : LEO THE LION
Price when posted : BSE: Rs 443.00 ( -2.01 % ), NSE: Rs. 446.85 ( -0.79 % )

This is not a stock to sell right now at 500+, hold for 2014-15........

Accmulate Cadila

Posted by : raj_shravan
Price when posted : BSE: Rs 464.15 ( 0.17 % ), NSE: Rs. 463.60 ( -0.29 % )

target is 545 and once thats crossed..it will touch 700 for sure...

Accmulate Cadila

Posted by : sam_pd
Price when posted : BSE: Rs 465.00 ( 0.36 % ), NSE: Rs. 463.60 ( -0.29 % )

pharma sectors are leading this rally. if goes above 500 then 25% profit booking advised....

Buy or Sell - Cadila

Posted by : SageSurya
Price when posted : BSE: Rs 463.35 ( 2.88 % ), NSE: Rs. 464.95 ( 3.31 % )

Cadila Healthcare is hitting multi year highs and looks a good candidate for medium and long term uptrend. I’d look for 20%+ returns in 1-2 months on the stock if the trade works out. Putting a stop around 420-425 might be appropriate in short term.

Investors should wait for dips in the stocks to accumulate.

- SageCapital...

NSE Announcements on Cadila Health

Posted by : MMB Messenger
Price when posted : [Cadila Health - BSE:Rs. 458.05 NSE:Rs. 238.15 when posted]

Cadila Healthcare Limited has informed the Exchange that Mr. Homi K. Bilpodiwala, director of the Company who was liable to retire by rotation at the Annual General Meeting of the Company held on July 29, 2009 had not offered himself for re-appointment. In view of the same, Mr. Homi K. Bilpodiwala ceased to be a director of the Company w.e.f. July 29, 2009 after conclusion of the Annual General Meeting....

BSE Announcements on Cadila Health

Posted by : MMB Messenger
Price when posted : [Cadila Health - BSE:Rs. 457.00 NSE:Rs. 238.15 when posted]

Cadila Healthcare Ltd has informed BSE that Mr. Homi K Bilpodiwala, director of the Company who was liable to retire by rotation at the 14th Annual General Meeting of the Company held July 29, 2009 had not offered himself for re-appointment.

In view of the same, Mr. Homi K Bilpodiwala ceased to be a director of the Company w.e.f July 29, 2009 after conclusion of the Annual General Meeting....

bn market drug

Posted by : LEO THE LION
Price when posted : BSE: Rs 460.80 ( 3.69 % ), NSE: Rs. 461.60 ( 4.68 % )

Only divestments with revenues of around 300 cr and EBITDA at 45 cr have paid 900 cr for wockhardt........
This is really great....!
This is the real value....